共 50 条
- [44] Exposure-Safety Analyses Identify Predictors of Change in Bone Mineral Density and Support Elagolix Labeling for Endometriosis-Associated Pain CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (11): : 639 - 648
- [45] Long-term persistence and switching patterns among women using osteoporosis therapies: 24- and 36-month results from POSSIBLE US™ Osteoporosis International, 2014, 25 : 2279 - 2290
- [49] Long-term efficacy, safety, and patient-reported outcomes of apitegromab in patients with spinal muscular atrophy: results from the 36-month TOPAZ study FRONTIERS IN NEUROLOGY, 2024, 15
- [50] Safety and efficacy of elagolix (with and without add-back therapy) for the treatment of heavy menstrual bleeding associated with uterine leiomyomas: a systematic review and meta-analysis Middle East Fertility Society Journal, 26